• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER CRIBRIFORM OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER CRIBRIFORM OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-MF-025
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Chest Pain (1776)
Event Date 02/26/2015
Event Type  Injury  
Event Description
A 25mm amplatzer cribriform occluder (aco) was successfully implanted on (b)(6) 2014.On (b)(6) 2015, the patient was admitted to the emergency room with acute chest pain.The mr images were not clear; however, reportedly the transesophageal echocardiogram confirmed a device erosion.The aco was endothelialized and was against the right atrium and aortic root.The patient was sent to surgery where the aco was removed.The patient was reported to be recovering and has been discharged.
 
Manufacturer Narrative
(b)(4).The results of this investigation are inconclusive because the aco was not returned for evaluation.A review of the device history record confirmed the aco met all visual, dimensional, and functional specifications at the time it was manufactured, prior to shipment.There was no evidence to suggest there was an intrinsic defect in the aco, and the cause for the reported event remains unknown.
 
Event Description
A 25mm amplatzer cribriform occluder (aco) was successfully implanted on (b)(6) 2014.On (b)(6) 2015, the patient was admitted to the emergency room with acute chest pain.The mr images were not clear; reportedly the transesophageal echocardiogram confirmed device erosion.The aco was endothelialized and was against the right atrium and aortic root.The patient was sent to surgery where erosion of the right atrial wall and partial erosion of the aortic wall (non-coronary sinus) was confirmed.The aco was removed and the wound and defect were repaired.The patient was reported to be recovering and has been discharged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER CRIBRIFORM OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key4625712
MDR Text Key19405132
Report Number2135147-2015-00039
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
P000039/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/03/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2019
Device Model Number9-ASD-MF-025
Device Catalogue Number9-ASD-MF-025
Device Lot Number4631278
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/03/2015
Initial Date FDA Received03/24/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received05/05/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/05/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age52 YR
-
-